4.0 Article

Embryonal and pineal tumours

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group

Shinji Yamashita et al.

Summary: This study aimed to evaluate the clinicopathological significance of pineal parenchymal tumors of intermediate differentiation (PPTIDs) by collecting patient data and conducting central pathology review and KBTBD4 mutation analysis. The results showed that female sex and gross total resection were independent prognostic factors. Leptomeningeal recurrence was found to be a characteristic feature of this tumor.

JOURNAL OF NEURO-ONCOLOGY (2023)

Review Clinical Neurology

Neuroimaging features of FOXR2-activated CNS neuroblastoma: A case series and systematic review

Kenichiro Shimazaki et al.

Summary: CNS NB-FOXR2 is a newly recognized tumor type in the classification of CNS tumors. It mainly affects children between 2 and 6 years old, and is characterized by imaging features such as hyperdense attenuation on CT and susceptibility abnormalities on MRI.

JOURNAL OF NEUROIMAGING (2023)

Article Neurosciences

Clinicopathological and molecular characterization of a case classified by DNA-methylation profiling as CNS embryonal tumor with BRD4-LEUTX fusion

Laetitia Lebrun et al.

Summary: In 2021, the CNS World Health Organization (WHO) classification introduced a new histo-molecular tumor type called CNS Embryonal Tumor with BRD4-LEUTX Fusion. We report a pediatric case of this novel tumor type, which showed highly aggressive features and loss of H3K27me3 protein expression. The patient presented with symptoms of headache, vomiting, and fever, and MRI examination revealed a large tumor in the left parietal lobe. Microscopic examination showed neuroectodermal features and the presence of the BRD4 (exon 13)-LEUTX (exon 2) fusion confirmed by RNA-sequencing analysis. This case highlights the importance of including this new subgroup in the CNS WHO classification.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Article Neurosciences

CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population

Arnault Tauziede-Espariat et al.

Summary: The Central Nervous System (CNS) tumor with BCOR internal tandem duplication (ITD) has been recognized as a novel embryonal histomolecular tumor type in the 2021 World Health Organization (WHO) Classification of CNS Tumors. Meanwhile, CNS tumors harboring a BCOR/BCORL1 fusion, characterized by a distinct DNA-methylation profile, have also been identified in recent literature. This study presents two adult cases of CNS tumors with EP300::BCOR fusion, which share similarities with CNS tumors having BCOR ITD in children. A literature review and meta-analysis indicate that CNS tumors with EP300::BCOR fusion are distinguishable from BCOR ITD tumors in terms of age, location, progression-free survival, tumor growth pattern, and immunopositivity for the BCOR protein. Thus, CNS tumors with EP300::BCOR fusion in adults may be included in future WHO classification.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Review Clinical Neurology

The oncogenic fusion landscape in pediatric CNS neoplasms

Mieke Roosen et al.

Summary: Pediatric neoplasms in the central nervous system (CNS) are a leading cause of cancer-related deaths in children. Recent molecular analyses have improved diagnosis and risk stratification of CNS tumors. Fusion proteins and oncogenic drivers are important in pediatric tumorigenesis.

ACTA NEUROPATHOLOGICA (2022)

Article Clinical Neurology

Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials

Anthony P. Y. Liu et al.

Summary: Methylation profiling has important implications for the classification and treatment of CNS-PNET. This study provides insights for clinical decision-making by analyzing the clinical and molecular features of pediatric CNS-PNET patients. Significant differences in treatment response and survival rates were observed among different molecular subgroups identified by DNA methylation profiling.

ACTA NEUROPATHOLOGICA (2022)

Article Oncology

Embryonal tumors with multilayered rosettes, C19MC-altered or not elsewhere classified: Clinicopathological characteristics, prognostic factors, and outcomes of 17 children from 2018 to 2022

Kailun Xu et al.

Summary: This study retrospectively analyzed the clinical, pathological features, and prognostic factors of ETMRs. ETANTRs may not present with typical morphologies during tumor progression. Children aged > 4 years tend to have a higher rate of metastasis in ETMRs. Chemotherapy is the only prognostic factor for ETMRs patients with a favorable prognosis.

FRONTIERS IN ONCOLOGY (2022)

Article Clinical Neurology

A case of desmoplastic myxoid tumor,SMARCB1mutant, in the pineal region

Yue-E. Wang et al.

Summary: A case of desmoplastic myxoid tumor (DMT), SMARCB1mutant, occurring in the pineal region has been reported in China for the first time, with similar epigenetic features to other tumors. The patient presented with symptoms of headaches, dizziness, nausea, vomiting, and blurred vision, and was diagnosed with DMT,SMARCB1mutant after surgical removal of the lesion. The findings also expanded the immunohistochemical phenotype range of this rare tumor.

NEUROPATHOLOGY (2021)

Article Clinical Neurology

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases

Dorthe Holdhof et al.

Summary: ATRTs are aggressive childhood malignancies of the central nervous system caused by inactivating mutations in SMARCB1 or SMARCA4 genes. SMARCB1 mutated ATRTs can be divided into three molecular subgroups, while ATRT-SMARCA4 represent a distinct molecular subgroup. The distinction is supported by DNA methylation and RNA sequencing analyses.

ACTA NEUROPATHOLOGICA (2021)

Article Clinical Neurology

C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center

Aruna Nambirajan et al.

Summary: CET is a group of tumors with poorly defined diagnostic criteria, diagnosed mainly by exclusion of other molecularly defined entities and histological mimics. A subset of CET can be subclassified using markers such as C19MC amplification, Lin28A, and Olig2, but the diagnostic specificity of these markers is limited and should be used in conjunction with other diagnostic methods.

CHILDS NERVOUS SYSTEM (2021)

Article Clinical Neurology

Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas

Till Holsten et al.

Summary: The study describes CNS NB FOXR2 tumors as a class of brain tumors with common genetic events and DNA methylation profiles. Histomorphological and immunohistochemical features were described, along with MRI findings for some cases. The study suggests that these tumors may fit well into the WHO entity of CNS neuroblastoma, providing helpful information for establishing an integrated diagnosis.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2021)

Article Pathology

Desmoplastic myxoid tumor, SMARCB1-mutant: a new variant of SMARCB1-deficient tumor of the central nervous system preferentially arising in the pineal region

Nozomi Matsumura et al.

Summary: Desmoplastic myxoid tumor (DMT), SMARCB1-mutant is a type of brain tumor that occurs in the pineal region of adults, characterized by desmoplastic stroma and varying degrees of myxoid matrix. Tumor cells show low-grade morphology and polyphenotypic immunoreactivity. While DMT, SMARCB1-mutant appears relatively benign, careful attention is required due to the genetic signature of concern associated with SMARCB1/INI1 deficiency.

VIRCHOWS ARCHIV (2021)

Article Clinical Neurology

Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study

Anthony P. Y. Liu et al.

Summary: A meta-analysis was conducted on 221 patients with molecularly characterized pineal parenchymal tumors, defining four clinically and biologically relevant consensus PB groups and a final PPTID group. Significant variations were observed in age, sex, and metastatic status among tumor groups, with different patient survival outcomes based on the molecular subgrouping.

ACTA NEUROPATHOLOGICA (2021)

Article Oncology

Melanotic Neuroectodermal Tumor of Infancy (MNTI) and Pineal Anlage Tumor (PAT) Harbor A Medulloblastoma Signature by DNA Methylation Profiling

Oscar Lopez-Nunez et al.

Summary: The study revealed a possible common histogenesis between melanotic neuroectodermal tumor of infancy (MNTI) and high-risk medulloblastoma, suggesting a potential molecular relationship. The molecular features of MNTI and pineal anlage tumor (PAT) show similarities, warranting further investigation.

CANCERS (2021)

Article Clinical Neurology

Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup

Francesca Zin et al.

Summary: This study aimed to investigate if morphological features of AT/RT might reflect molecular alterations and provide a first hint on molecular subgroup status, which will need to be confirmed by DNA methylation profiling.

BRAIN PATHOLOGY (2021)

Review Oncology

Pineal Gland Tumors: A Review

Gaia Favero et al.

Summary: This article discusses the classification, diagnosis, and clinical management of pineal tumors, emphasizing the importance of studying the triggering causes to make accurate diagnoses and proper therapeutic interventions.

CANCERS (2021)

Article Oncology

Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study

Katja von Hoff et al.

Summary: After molecular classification of CNS-PNET based on DNA methylation analysis, the treatment outcomes of patients become highly variable. Patients with CNS NB-FOXR2 responded well to current treatments, while those with ETMR had the worst outcomes.

NEURO-ONCOLOGY (2021)

Review Clinical Neurology

An update on the central nervous system manifestations of DICER1 syndrome

Leanne de Kock et al.

ACTA NEUROPATHOLOGICA (2020)

Review Clinical Neurology

ETMR: a tumor entity in its infancy

Sander Lambo et al.

ACTA NEUROPATHOLOGICA (2020)

Article Oncology

Central nervous system ganglioneuroblastoma harboringMYO5A-NTRK3fusion

Jumpei Ito et al.

BRAIN TUMOR PATHOLOGY (2020)

Article Multidisciplinary Sciences

Childhood cerebellar tumours mirror conserved fetal transcriptional programs

Maria C. Vladoiu et al.

NATURE (2019)

Article Multidisciplinary Sciences

The molecular landscape of ETMR at diagnosis and relapse

Sander Lambo et al.

NATURE (2019)

Article Multidisciplinary Sciences

DNA methylation-based classification of central nervous system tumours

David Capper et al.

NATURE (2018)

Article Oncology

Intertumoral Heterogeneity within Medulloblastoma Subgroups

Florence M. G. Cavalli et al.

CANCER CELL (2017)

Article Clinical Neurology

Papillary Tumor of the Pineal Region: A Distinct Molecular Entity

Stephanie Heim et al.

BRAIN PATHOLOGY (2016)

Article Medicine, Research & Experimental

p53 and Meduloblastoma

Vijay Ramaswamy et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Article Biochemistry & Molecular Biology

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Dominik Sturm et al.

Article Medical Laboratory Technology

Cytologic features of papillary tumor of the pineal region: A case report showing tigroid background

Jose A. Jimenez-Heffernan et al.

DIAGNOSTIC CYTOPATHOLOGY (2016)

Article Medical Laboratory Technology

Cytologic features of the normal pineal gland of adults

Jose A. Jimenez-Heffernan et al.

DIAGNOSTIC CYTOPATHOLOGY (2015)

Article Medical Laboratory Technology

Cytologic Features of the Normal Pineal Gland on Squash Preparations

Diana Murro et al.

DIAGNOSTIC CYTOPATHOLOGY (2014)

Article Clinical Neurology

Biological and clinical heterogeneity of MYCN-amplified medulloblastoma

Andrey Korshunov et al.

ACTA NEUROPATHOLOGICA (2012)

Article Clinical Neurology

Molecular subgroups of medulloblastoma: the current consensus

Michael D. Taylor et al.

ACTA NEUROPATHOLOGICA (2012)

Article Multidisciplinary Sciences

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

Trevor J. Pugh et al.

NATURE (2012)

Article Clinical Neurology

Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study

M. Fevre-Montange et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)

Review Oncology

Medulloblastomics: the end of the beginning

Paul A. Northcott et al.

NATURE REVIEWS CANCER (2012)

Article Clinical Neurology

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

David W. Ellison et al.

ACTA NEUROPATHOLOGICA (2011)

Article Clinical Neurology

Ependymoblastoma: Dear, Damned, Distracting Diagnosis, Farewell!

Alexander R. Judkins et al.

BRAIN PATHOLOGY (2010)

Article Oncology

Factors influencing overall survival rates for patients with pineocytoma

Aaron J. Clark et al.

JOURNAL OF NEURO-ONCOLOGY (2010)

Article Genetics & Heredity

Germline mutation of INI1/SMARCB1 in familial schwannomatosis

Theo J. M. Hulsebos et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2007)

Article Clinical Neurology

Prognosis and histopathologic features in papillary tumors of the pineal region: A retrospective multicenter study of 31 cases

Michelle Fevre-Montange et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Clinical Neurology

Immunohistochemical profile and chromosomal imbalances in papillary tumours of the pineal region

M Hasselblatt et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2006)

Article Pathology

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms

AR Judkins et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)

Article Clinical Neurology

Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia

CG Eberhart et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)

Article Pathology

Papillary tumor of the pineal region

A Jouvet et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)

Article Pathology

Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes

CG Eberhart et al.

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2000)